Fiala, O.; Ostasov, P.; Sorejs, O.; Liska, V.; Buchler, T.; Poprach, A.; Finek, J.
Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients. Cancers 2019, 11, 1856.
https://doi.org/10.3390/cancers11121856
AMA Style
Fiala O, Ostasov P, Sorejs O, Liska V, Buchler T, Poprach A, Finek J.
Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients. Cancers. 2019; 11(12):1856.
https://doi.org/10.3390/cancers11121856
Chicago/Turabian Style
Fiala, Ondrej, Pavel Ostasov, Ondrej Sorejs, Vaclav Liska, Tomas Buchler, Alexandr Poprach, and Jindrich Finek.
2019. "Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients" Cancers 11, no. 12: 1856.
https://doi.org/10.3390/cancers11121856
APA Style
Fiala, O., Ostasov, P., Sorejs, O., Liska, V., Buchler, T., Poprach, A., & Finek, J.
(2019). Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients. Cancers, 11(12), 1856.
https://doi.org/10.3390/cancers11121856
